NKGen Biotech’s mission is to become the global leader in natural killer cell therapy.
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform. Spearheading our industry disrupting technology are our Senior Leadership, Senior Advisors and Management Team. Together they bring a wealth of knowledge and expertise in the immune-oncology space and are passionate and excited about the work we are doing to strengthen the immune system.
